NUCYCLE THERAPY INC
15-12G, 2000-08-07
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SATURN ELECTRONICS & ENGINEERING INC, 8-A12B, 2000-08-07
Next: AVANTGO INC, S-1/A, 2000-08-07



<PAGE>

                                    FORM 15


                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549


Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934.

                                             Commission File Number   0-30605
                                                                      -------

                             NUCYCLE THERAPY, INC.
                             ---------------------
            (Exact name of registrant as specified in its charter)

                             NuCycle Therapy, Inc.
    1 Deer Park Drive, Suite M, Monmouth Junction, NJ 08852 (732) 438-0900
     ---------------------------------------------------------------------
         (Address, including zip code, and telephone number, including
            area code, of registrant's principal executive offices)


                                 Common Stock
            ------------------------------------------------------
           (Title of each class of securities covered by this Form)

                                     None
                                     ----
             (Title of all other classes of securities for which a
          duty to file reports under Section 13(a) or 15(d) remains)

        Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:

             Rule 12g-4(a)(1)(i)  [X]    Rule 12h-3(b)(1)(i)  [X]
             Rule 12g-4(a)(1)(ii) [ ]    Rule 12h-3(b)(1)(ii) [ ]
             Rule 12g-4(a)(2)(i)  [ ]    Rule 12h-3(b)(2)(i)  [ ]
             Rule 12g-4(a)(2)(ii) [ ]    Rule 12h-3(b)(2)(ii) [ ]
                                         Rule 15d-6           [ ]

        Approximate number of holders of record as of the certification or
notice date: 290

        Pursuant to the requirements of the Securities Exchange Act of 1934,
NuCycle Therapy, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.

                                 NuCycle Therapy, Inc.


DATE:  August 4, 2000            By: /s/ Burt D. Ensley
                                    --------------------
                                 Name:  Burt D. Ensley
                                 Title:  President

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission